Structures by: Laufer S.
Total: 69
Poly[[tetramethanolbis[4-oxo-3-(pyridin-4-yl)-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6-olato]disodium]--diethyl ether--methanol (1/1/2)]
2(C16H7Cl3N5NaO2),C4H10O,6(CH4O)
IUCrData (2016) 1, 7 x161081
a=11.1721(7)Å b=8.1249(5)Å c=28.8799(18)Å
α=90° β=100.2130(10)° γ=90°
Mo3O12Y2
Mo3O12Y2
New Journal of Chemistry (2013) 37, 7 1919
a=10.3021(3)Å b=10.3241(3)Å c=10.5725(3)Å
α=90.00° β=90.00° γ=90.00°
Mo3O12Y2
Mo3O12Y2
New Journal of Chemistry (2013) 37, 7 1919
a=7.2927(2)Å b=7.2927(2)Å c=10.5726(3)Å
α=90.00° β=90.00° γ=90.00°
Mo4O15Y2
Mo4O15Y2
New Journal of Chemistry (2013) 37, 7 1919
a=6.8185(2)Å b=9.5913(3)Å c=10.5299(3)Å
α=90.00° β=105.586(2)° γ=90.00°
4-(4-Fluorophenyl)-3-pyridin-4-ylquinolin-2(1H)-one
C20H13FN2O
Acta Crystallographica Section E (2006) 62, 7 o2648-o2650
a=27.771(2)Å b=8.2247(4)Å c=15.2643(12)Å
α=90.00° β=117.466(3)° γ=90.00°
3-(4-fluorophenyl)-4-(4-pyridyl)quinolin-2(1H)-one
C20H13FN2O
Acta Crystallographica Section E (2006) 62, 6 o2475-o2477
a=9.434(5)Å b=9.9087(16)Å c=16.789(9)Å
α=90.00° β=97.32(3)° γ=90.00°
(3RS,1SR)-3-Bromo-3-(1-phenylpropyl)chroman-2,4-dione
C18H15BrO3
Acta Crystallographica Section E (2005) 61, 4 o868-o869
a=6.2769(16)Å b=8.6095(10)Å c=14.775(3)Å
α=91.154(12)° β=90.796(18)° γ=103.908(14)°
4-[5-(4-Fluorophenyl)-3-isopropylisoxazol-4-yl]pyridin-2(1H)-one
C17H15FN2O2
Acta Crystallographica Section E (2007) 63, 3 o1423-o1425
a=14.6895(7)Å b=7.3663(2)Å c=14.2056(6)Å
α=90.00° β=100.266(5)° γ=90.00°
(1aR,2aS,5aS,5bS)-Perhydro-4H-oxireno[3,4]cyclopenta[1,2-b]furan-4-one
C7H8O3
Acta Crystallographica Section E (2007) 63, 3 o1359-o1360
a=4.8759(5)Å b=9.5110(8)Å c=14.1724(11)Å
α=90.00° β=90.00° γ=90.00°
N-{(Z)-2-[1-(Triisopropylsilyl)-1H-indol-3-yl]-2-(triisopropylsilyloxy)vinyl}-2- (3,4,5-trimethoxyphenyl)acetamide
C39H62N2O5Si2
Acta Crystallographica Section E (2007) 63, 3 o1266-o1268
a=9.0114(13)Å b=14.886(2)Å c=16.023(2)Å
α=87.639(4)° β=84.428(4)° γ=76.011(4)°
3-(4-Fluorophenyl)-1-methyl-4-(4-pyridyl)quinolin-2(1<i>H</i>)-one
C21H15FN2O
Acta Crystallographica Section E (2007) 63, 5 o2457-o2459
a=9.3217(6)Å b=18.1539(11)Å c=9.9297(7)Å
α=90.00° β=105.259(4)° γ=90.00°
2-(6-Amino-7<i>H</i>-purin-7-yl)-1-phenylethanone
C13H11N5O
Acta Crystallographica Section E (2007) 63, 12 o4646-o4647
a=5.2098(9)Å b=17.738(3)Å c=13.046(3)Å
α=90.00° β=97.998(19)° γ=90.00°
4-[4-(4-Fluorophenyl)-2-methyl-5-oxo-2,5-dihydroisoxazol-3-yl]-1- methylpyridinium iodide-- 4-[3-(4-fluorophenyl)-2-methyl-5-oxo-2,5-dihydroisoxazol-4-yl]-1-methyl- pyridinium iodide (0.6/0.4)
C15H12FN2O2,I
Acta Crystallographica Section E (2008) 64, 1 o298-o299
a=10.2804(4)Å b=20.5895(9)Å c=7.4907(3)Å
α=90.00° β=96.8828(14)° γ=90.00°
3-(2-Fluorophenyl)-6-(phenoxymethyl)-1,2,4-triazolo[3,4- <i>b</i>][1,3,4]thiadiazole
C16H11FN4OS
Acta Crystallographica Section E (2008) 64, 4 o700
a=10.8551(6)Å b=12.1899(3)Å c=11.6667(6)Å
α=90.00° β=110.857(5)° γ=90.00°
6-Amino-1-benzyl-4-(4-chlorophenyl)-3-(4-pyridyl)-1,4- dihydropyrano[2,3-<i>c</i>]pyrazole-5-carbonitrile
C25H18ClN5O
Acta Crystallographica Section E (2008) 64, 4 o701
a=5.7021(11)Å b=17.795(3)Å c=21.056(9)Å
α=90.00° β=90.954(8)° γ=90.00°
(4R)-4-Hydroxy-1-[(2S)-2-hydroxydodecyl]-L-proline monohydrate
C17H33NO4,H2O
Acta Crystallographica Section E (2006) 62, 11 o5138-o5140
a=5.4341(2)Å b=7.8324(2)Å c=46.6831(10)Å
α=90.00° β=90.00° γ=90.00°
3,4-bis(4-fluorophenyl)-1,2,5-oxadiazole 2-oxide
C14H8F2N2O2
Acta Crystallographica Section E (2006) 62, 11 o4827-o4828
a=17.797(2)Å b=10.3032(7)Å c=14.2799(14)Å
α=90.00° β=111.251(10)° γ=90.00°
2-(6-Methoxy-7H-purine-7-yl)-1-phenylethanone
C14H12N4O2,H2O
Acta Crystallographica Section E (2007) 63, 10 o4154-o4155
a=12.2729(6)Å b=8.2830(7)Å c=14.3335(10)Å
α=90.00° β=112.851(3)° γ=90.00°
4-(4-Fluorophenyl)-2-methyl-3-(1-oxy-4-pyridyl)isoxazol-5(2H)-one
C15H11FN2O3
Acta Crystallographica Section E (2008) 64, 2 o504-o504
a=10.0828(6)Å b=10.0828(6)Å c=25.257(5)Å
α=90.00° β=90.00° γ=90.00°
4-[5-(4-fluorophenyl)-3-isopropylisoxazol-4-yl]pyridine
C17H15FN2O
Acta Crystallographica Section E (2006) 62, 9 o3647-o3649
a=14.1426(10)Å b=11.8646(9)Å c=17.8516(13)Å
α=90.00° β=105.475(4)° γ=90.00°
4-[3-(4-fluorophenyl)-5-isopropylisoxazol-4-yl]pyridine
C17H15FN2O
Acta Crystallographica Section E (2006) 62, 9 o3707-o3709
a=15.490(2)Å b=11.4393(9)Å c=17.878(3)Å
α=90.00° β=110.838(7)° γ=90.00°
Ethyl 2,3-dihydro-1H,1'H-2,3'-biindol-1-yl(oxo)acetate
C20H18N2O3
Acta Crystallographica Section E (2007) 63, 3 o1415-o1417
a=8.441(3)Å b=9.596(3)Å c=10.925(4)Å
α=96.11(2)° β=96.49(3)° γ=106.13(2)°
Rac-(3E,3aR,6aR)-3-(Hydroxymethylene)- 3,3a,6,6a-tetrahydro-2H-cyclopenta[b]furan-2-one
C8H8O3
Acta Crystallographica Section E (2007) 63, 4 o1551-o1553
a=11.9618(2)Å b=8.5709(8)Å c=16.127(3)Å
α=90.00° β=117.741(7)° γ=90.00°
2,2-Dimethyl-N-[3-(3,4,5-trimethoxybenzoyl)pyridin-4-yl]propanamide
C20H24N2O5
Acta Crystallographica Section E (2007) 63, 4 o1887-o1889
a=11.5962(4)Å b=13.8654(3)Å c=24.0393(9)Å
α=90.00° β=94.9946(18)° γ=90.00°
(2aRS,3RS,4aSR,6aRS,6bSR)-3-Hydroxy-2a,3,4a,6,6a,6b-hexahydro-1,4- dioxacyclopenta[cd]pentalen-2(5H)-one
C8H10O4
Acta Crystallographica Section E (2007) 63, 5 o2249-o2251
a=9.7712(6)Å b=10.0443(3)Å c=8.1779(5)Å
α=90.00° β=112.568(3)° γ=90.00°
Methyl 4-[5-(4-fluorophenyl)-4-(pyridin-4-yl)-1<i>H</i>-imidazol-2-ylsulfanyl]butanoate
C19H18FN3O2S
Acta Crystallographica Section E (2008) 64, 7 o1183-o1184
a=18.494(4)Å b=12.4367(10)Å c=7.5255(5)Å
α=90.00° β=90.00° γ=90.00°
2-(4-Fluorophenyl)-1-(4-pyridyl)cyclopentan-1-ol
C16H16FNO
Acta Crystallographica Section E (2007) 63, 8 o3531-o3531
a=11.7228(8)Å b=13.6606(8)Å c=8.6194(11)Å
α=90.00° β=104.366(10)° γ=90.00°
<i>tert</i>-Butyl <i>N</i>-(4-methyl-2-pyridyl)carbamate
C11H16N2O2
Acta Crystallographica Section E (2008) 64, 11 o2216
a=10.5850(6)Å b=11.6854(6)Å c=18.5568(15)Å
α=90.00° β=90.00° γ=90.00°
<i>tert</i>-Butyl <i>N</i>-benzyl-<i>N</i>-[4-(4-fluorobenzoylmethyl)-2-pyridyl]carbamate
C25H25FN2O3
Acta Crystallographica Section E (2008) 64, 11 o2221
a=38.054(7)Å b=7.9320(6)Å c=14.589(3)Å
α=90.00° β=102.142(8)° γ=90.00°
4-[3-(4-Fluorophenyl)quinoxalin-2-yl]-<i>N</i>-isopropylpyridin-2-amine
C22H19FN4
Acta Crystallographica Section E (2009) 65, 6 o1344
a=17.230(9)Å b=5.386(3)Å c=19.123(10)Å
α=90.00° β=96.114(13)° γ=90.00°
2-[(1-Methyl-1<i>H</i>-pyrrol-2-yl)carbonylmethyl]isoindoline-1,3-dione
C15H12N2O3
Acta Crystallographica Section E (2009) 65, 10 o2375
a=10.8897(7)Å b=14.8466(4)Å c=15.8200(9)Å
α=90.00° β=101.619(3)° γ=90.00°
3-(4-Fluorophenyl)-2-(4-pyridyl)pyrido[2,3-<i>b</i>]pyrazine
C18H11FN4
Acta Crystallographica Section E (2009) 65, 10 o2546
a=9.7163(9)Å b=13.7937(6)Å c=10.8164(10)Å
α=90.00° β=90.994(5)° γ=90.00°
4-[2-(4-Fluorophenyl)-1<i>H</i>-pyrrol-3-yl]pyridine
C15H11FN2
Acta Crystallographica Section E (2009) 65, 3 o457
a=9.2966(7)Å b=8.1966(5)Å c=30.5738(19)Å
α=90.00° β=90.00° γ=90.00°
4-[2-(4-Fluorophenyl)furan-3-yl]pyridine
C15H10FNO
Acta Crystallographica Section E (2009) 65, 3 o458
a=13.343(9)Å b=10.550(3)Å c=8.178(5)Å
α=90.00° β=94.44(3)° γ=90.00°
2-(Bicyclo[2.2.1]hept-5-en-2-yl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine
C14H14N2
Acta Crystallographica Section E (2010) 66, 7 o1800
a=7.7837(12)Å b=8.9867(14)Å c=15.973(3)Å
α=90.00° β=96.408(8)° γ=90.00°
3-(2,4-Difluoroanilino)-9-nitrodibenzo[<i>b</i>,<i>e</i>]oxepin- 11(6<i>H</i>)-one
C20H12F2N2O4
Acta Crystallographica Section E (2011) 67, 3 o555
a=27.0813(15)Å b=13.0411(8)Å c=4.5998(2)Å
α=90.00° β=90.00° γ=90.00°
<i>tert</i>-Butyl <i>N</i>-benzyl-<i>N</i>-(4-methyl-2-pyridyl)carbamate
C18H22N2O2
Acta Crystallographica Section E (2008) 64, 11 o2222
a=5.9090(10)Å b=9.7779(18)Å c=14.199(7)Å
α=89.683(13)° β=87.968(14)° γ=83.963(15)°
4-[5-(4-Fluorophenyl)-1<i>H</i>-imidazol-4-yl]pyridine
C14H10FN3
Acta Crystallographica Section E (2009) 65, 3 o573
a=9.217(2)Å b=8.1064(5)Å c=30.665(5)Å
α=90.00° β=90.00° γ=90.00°
1-[2-(Benzylamino)-4-pyridyl]-2-(4-fluorophenyl)ethane-1,2-dione
C20H15FN2O2
Acta Crystallographica Section E (2009) 65, 6 o1451
a=12.0951(13)Å b=7.4097(8)Å c=35.163(5)Å
α=90.00° β=90.00° γ=90.00°
3-(4-Fluorophenyl)-6-methoxy-2-(4-pyridyl)quinoxaline
C20H14FN3O
Acta Crystallographica Section E (2009) 65, 7 o1626
a=7.3886(4)Å b=12.2071(8)Å c=34.562(6)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-{4-[3-(4-Fluorophenyl)pyrido[2,3-<i>b</i>]pyrazin-2-yl]- 2-pyridyl}isopropylamine
C21H18FN5
Acta Crystallographica Section E (2009) 65, 10 o2557
a=12.0420(10)Å b=7.6586(2)Å c=20.095(2)Å
α=90.00° β=100.215(5)° γ=90.00°
2-(4-Fluorophenyl)-3-(4-pyridyl)pyrido[2,3-<i>b</i>]pyrazine
C18H11FN4
Acta Crystallographica Section E (2009) 65, 10 o2512
a=17.222(9)Å b=11.2199(12)Å c=7.329(4)Å
α=90.00° β=91.80(3)° γ=90.00°
4-(4-Fluorophenyl)-1-methoxymethyl-2-phenyl-1<i>H</i>-imidazole
C17H15FN2O
Acta Crystallographica Section E (2009) 65, 11 o2803
a=10.5240(10)Å b=11.2480(11)Å c=11.9810(12)Å
α=90.00° β=92.206(3)° γ=90.00°
4-Chloro-1-(4-methylphenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine
C14H11ClN2O2S
Acta Crystallographica Section E (2009) 65, 12 o3018
a=21.7342(12)Å b=7.6313(2)Å c=16.4649(8)Å
α=90.00° β=91.531(2)° γ=90.00°
2-(3,4,5-Trimethoxyphenyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine
C16H16N2O3
Acta Crystallographica Section E (2009) 65, 12 o3097
a=7.6283(9)Å b=10.1745(4)Å c=18.604(2)Å
α=90.00° β=104.778(6)° γ=90.00°
<i>N</i>-{4-[4-(4-Fluorophenyl)-1-(2-methoxyethyl)-2-methylsulfanyl- 1<i>H</i>-imidazol-5-yl]-2-pyridyl}-2-methyl-3-phenylpropionamide
C28H29FN4O2S
Acta Crystallographica Section E (2009) 65, 12 o3128
a=10.6254(5)Å b=28.5420(10)Å c=9.8380(4)Å
α=90.00° β=117.9530(10)° γ=90.00°
(2<i>Z</i>)-2-Fluoro-<i>N</i>-{4-[5-(4-fluorophenyl)-2-methylsulfanyl- 1<i>H</i>-imidazol-4-yl]-2-pyridyl}-3-phenylacrylamide
C24H18F2N4OS
Acta Crystallographica Section E (2009) 65, 12 o3284
a=20.6370(10)Å b=7.8413(5)Å c=26.256(2)Å
α=90.00° β=93.456(4)° γ=90.00°
<i>N</i>-{4-[4-(4-Fluorophenyl)-1-methyl-2-[(<i>R</i>)-methylsulfinyl]- 1<i>H</i>-imidazol-5-yl]-2-pyridyl}acetamide dihydrate
C18H17FN4O2S,2H2O
Acta Crystallographica Section E (2010) 66, 1 o121
a=5.8178(2)Å b=14.3233(5)Å c=23.3694(9)Å
α=90.00° β=90.00° γ=90.00°
7-[4-(4-Fluorophenyl)-2-methylsulfanyl-1<i>H</i>-imidazol- 5-yl]tetrazolo[1,5-<i>a</i>]pyridine
C15H11FN6S
Acta Crystallographica Section E (2010) 66, 2 o451
a=9.8342(7)Å b=18.1908(6)Å c=8.2374(7)Å
α=90.00° β=100.292(3)° γ=90.00°
4-Chloro-7-methoxymethyl-2-phenyl-7<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine
C15H13ClN2O
Acta Crystallographica Section E (2010) 66, 4 o822
a=8.4785(8)Å b=9.6576(10)Å c=15.8560(16)Å
α=90.00° β=90.00° γ=90.00°
5-(4-Fluorophenyl)-4-(4-pyridyl)-1,3-oxazol-2-amine
C14H10FN3O
Acta Crystallographica Section E (2010) 66, 4 o917
a=10.1017(4)Å b=8.3889(8)Å c=29.127(2)Å
α=90.00° β=90.00° γ=90.00°
2-(4-Fluorophenyl)-<i>N</i>-{4-[6-(4-fluorophenyl)-2,3- dihydroimidazo[2,1-<i>b</i>][1,3]thiazol-5-yl]pyridin-2-yl}acetamide
C24H18F2N4OS
Acta Crystallographica Section E (2010) 66, 5 o1132
a=4.9179(3)Å b=23.5920(10)Å c=18.4834(9)Å
α=90.00° β=91.523(2)° γ=90.00°
<i>N</i>-(4-Chloropyridin-2-yl)-<i>N</i>-methoxymethyl- 4-methylbenzenesulfonamide
C14H15ClN2O3S
Acta Crystallographica Section E (2010) 66, 12 o3321
a=15.1651(10)Å b=22.7953(13)Å c=8.9132(6)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-(4-chloropyridin-2-yl)-<i>N</i>-tosylacetamide
C14H13ClN2O3S
Acta Crystallographica Section E (2010) 66, 12 o3320
a=12.578(2)Å b=7.5460(8)Å c=30.194(3)Å
α=90.00° β=90.00° γ=90.00°
3-(2,4-Dimethoxyanilino)-8-methoxydibenz[<i>b</i>,<i>e</i>]oxepin- 11(6<i>H</i>)-one
C23H21NO5
Acta Crystallographica Section E (2011) 67, 2 o487
a=9.3277(9)Å b=25.8290(8)Å c=7.9519(6)Å
α=90.00° β=98.914(3)° γ=90.00°
4-(4-Fluorophenyl)-3-(pyridin-4-yl)-1-(2,4,6-trichlorophenyl)-1<i>H</i>- pyrazol-5-amine
C20H12Cl3FN4
Acta Crystallographica Section E (2012) 68, 9 o2603
a=10.2487(5)Å b=10.4643(5)Å c=10.5489(5)Å
α=109.2377(10)° β=111.4008(10)° γ=98.0304(11)°
6-(4-Chlorophenyl)-7-phenyl-2,3-dihydro-1<i>H</i>-pyrrolizine-5-carbaldehyde
C20H16ClNO
Acta Crystallographica Section E (2011) 67, 9 o2292
a=21.1526(13)Å b=11.5723(9)Å c=17.1484(12)Å
α=90.00° β=130.843(4)° γ=90.00°
6-(4-Methoxyphenyl)-7-phenyl-2,3-dihydro-1<i>H</i>-pyrrolizine-5-carbaldehyde
C21H19NO2
Acta Crystallographica Section E (2011) 67, 9 o2417
a=12.2276(17)Å b=9.1557(10)Å c=15.462(2)Å
α=90.00° β=104.174(11)° γ=90.00°
1,4-Dimethyl-2-phenyl-6,7-dihydro-1<i>H</i>-pyrazolo[4,3-<i>b</i>]pyridine- 3,5(2<i>H</i>,4<i>H</i>)-dione
C14H15N3O2
Acta Crystallographica Section E (2011) 67, 10 o2586
a=8.9721(7)Å b=21.7653(19)Å c=7.3725(5)Å
α=90.00° β=120.214(5)° γ=90.00°
4-(4-Fluorophenyl)-1-phenyl-3-(pyridin-4-yl)-1<i>H</i>-pyrazol-5-amine
C20H15FN4
Acta Crystallographica Section E (2012) 68, 3 o632
a=12.2408(3)Å b=10.4427(2)Å c=12.9099(3)Å
α=90.00° β=101.9510(10)° γ=90.00°
4-(4-Fluorophenyl)-1-(4-nitrophenyl)-3-(pyridin-4-yl)-1<i>H</i>-pyrazol- 5-amine
C20H14FN5O2
Acta Crystallographica Section E (2012) 68, 3 o633
a=8.5088(14)Å b=9.8797(11)Å c=10.4264(14)Å
α=79.906(10)° β=78.764(10)° γ=86.245(9)°
Ethyl 5-amino-3-(pyridin-4-yl)-1-(2,4,6-trichlorophenyl)-1<i>H</i>-pyrazole-4- carboxylate dimethyl sulfoxide hemisolvate
C17H13Cl3N4O2,0.5(C2H6OS)
Acta Crystallographica Section E (2012) 68, 3 o917-o918
a=13.501(2)Å b=10.3222(15)Å c=14.889(2)Å
α=90.00° β=100.453(5)° γ=90.00°
4-[5-Amino-4-(4-fluorophenyl)-3-(pyridin-4-yl)-1<i>H</i>- pyrazol-1-yl]benzonitrile
C21H14FN5
Acta Crystallographica Section E (2012) 68, 4 o935
a=10.5189(5)Å b=8.1339(3)Å c=20.0009(13)Å
α=90.00° β=90.00° γ=90.00°
1-[(3<i>RS</i>,4<i>RS</i>)-1-Benzyl-4-methylpiperidin-3-yl]- 1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridine hemihydrate
C21H23N5,0.5(H2O)
Acta Crystallographica Section E (2012) 68, 10 o3052
a=17.3606(19)Å b=10.0422(10)Å c=22.995(2)Å
α=90.00° β=100.965(3)° γ=90.00°
<i>N</i>-[(3<i>RS</i>,4<i>RS</i>)-1-Benzyl-4-methylpiperidin-3-yl]- 5-nitro-1-phenylsulfonyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-4-amine
C27H29N5O4S
Acta Crystallographica Section E (2012) 68, 10 o3051
a=17.2626(10)Å b=11.5411(8)Å c=13.1313(9)Å
α=90.00° β=98.443(3)° γ=90.00°
3-(4-Bromophenyl)-1-phenyl-1<i>H</i>-pyrazole-4-carbaldehyde
C16H11BrN2O
Acta Crystallographica Section E (2012) 68, 12 o3397
a=9.6716(8)Å b=11.4617(9)Å c=13.8257(10)Å
α=113.497(5)° β=92.753(6)° γ=93.753(6)°
2-[5-Bromo-1-(3-chlorobenzyl)-2-methyl-1<i>H</i>-indol-3-yl]acetic acid
C18H15BrClNO2
Acta Crystallographica Section E (2012) 68, 12 o3396
a=8.5386(11)Å b=10.0157(10)Å c=11.0821(12)Å
α=109.221(8)° β=106.229(9)° γ=101.886(9)°
<i>tert</i>-Butyl <i>N</i>-[(3<i>R</i>,4<i>R</i>)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl]-<i>N</i>-methylcarbamate
C15H25N3O3
Acta Crystallographica Section E (2013) 69, 6 o935
a=7.1786(11)Å b=7.3213(10)Å c=16.042(2)Å
α=90.00° β=102.196(4)° γ=90.00°
<i>N</i>-[(3<i>RS</i>,4<i>SR</i>)-1-Benzyl-4-methylpiperidin-3-yl]-1-(4- methylphenylsulfonyl)-5-nitro-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-amine
C27H29N5O4S
Acta Crystallographica Section E (2012) 68, 10 o3000
a=29.5164(12)Å b=9.1388(2)Å c=23.3008(9)Å
α=90.00° β=124.803(3)° γ=90.00°